FDA Extends Comment Period for Draft Guidance on Medical Device Clinical Studies

Summary

The Food and Drug Administration (FDA) is extending the comment period for a draft guidance on early feasibility medical device clinical studies, including certain first-in-human studies, to allow more time for public input.